New Delhi, November 26
Amid a surge in the Covid-19 caseload which rose to 92,66,705 today, Prime Minister Narendra Modi is scheduled to visit India’s vaccine manufacturing hubs this weekend to take stock of the development progress.
The PM will go to the Serum Institute of India, Pune, on Saturday followed by a visit to the Hyderabad-based Bharat Biotech.
While the serum institute is the Indian collaborator of the Oxford University-AstraZeneca vaccine project (Covishield), Bharat Biotech is partnering with the ICMR to develop one (Covaxin) of the two indigenous vaccines.
Trials of Covishield and Covaxin have entered the third phase. Covaxin Phase-3 trials began at AIIMS today with senior doctors taking the shots to inspire public confidence in the project.
The PM’s visit plan comes at a time when India has started to see a trend of new cases exceeding new recoveries. In the last 24 hours there were 44,489 new infections as against 36,367 new recoveries. Of the new cases, 60.72 per cent are from six states —- Kerala, Maharashtra, Delhi, West Bengal, Rajasthan and Uttar Pradesh. Kerala saw the maximum (6,491) fresh cases followed by Maharashtra 6,159 and Delhi 5,246.
Among the active cases, 65 per cent are from eight states, including Punjab and Haryana. — TNS